The implications of mpox breakthrough infections on future vaccination strategies

Marc C. Shamier; Luca M. Zaeck; Rory D. de Vries; Corine H. GeurtsvanKessel

doi:10.1016/S1473-3099(23)00518-2

The implications of mpox breakthrough infections on future vaccination strategies

Marc C. Shamier^*
, Luca M. Zaeck
, Rory D. de Vries
, Corine H. GeurtsvanKessel

^*Corresponding author for this work

Virology

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

1 Citation (Scopus)

12 Downloads (Pure)

Original language	English
Pages (from-to)	6-8
Number of pages	3
Journal	The Lancet Infectious Diseases
Volume	24
Issue number	1
Early online date	4 Sept 2023
DOIs	https://doi.org/10.1016/S1473-3099(23)00518-2
Publication status	Published - Jan 2024

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S1473-3099(23)00518-2

The implications of mpox breakthrough infections on future vaccination strategiesFinal published version, 164 KBLicence: Article 25fa Dutch Copyright Act

Cite this

@article{7d21f9edc97b4ebc9526152f94f6c3da,

title = "The implications of mpox breakthrough infections on future vaccination strategies",

author = "Shamier, \{Marc C.\} and Zaeck, \{Luca M.\} and \{de Vries\}, \{Rory D.\} and GeurtsvanKessel, \{Corine H.\}",

year = "2024",

month = jan,

doi = "10.1016/S1473-3099(23)00518-2",

language = "English",

volume = "24",

pages = "6--8",

journal = "The Lancet Infectious Diseases",

issn = "1473-3099",

publisher = "Elsevier Ltd.",

number = "1",

}

TY - JOUR

T1 - The implications of mpox breakthrough infections on future vaccination strategies

AU - Shamier, Marc C.

AU - Zaeck, Luca M.

AU - de Vries, Rory D.

AU - GeurtsvanKessel, Corine H.

PY - 2024/1

Y1 - 2024/1

UR - https://www.scopus.com/pages/publications/85172342927

U2 - 10.1016/S1473-3099(23)00518-2

DO - 10.1016/S1473-3099(23)00518-2

M3 - Comment/Letter to the editor

C2 - 37678310

AN - SCOPUS:85172342927

SN - 1473-3099

VL - 24

SP - 6

EP - 8

JO - The Lancet Infectious Diseases

JF - The Lancet Infectious Diseases

IS - 1

ER -

The implications of mpox breakthrough infections on future vaccination strategies

UN SDGs

Access to Document

Other files and links

Cite this